Immune inflammation indicators and ALBI score to predict occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

被引：11
|
作者：
Gardini, A. C. [1 ]
Foschi, F. G. [2 ]
Conti, F. [3 ]
Petracci, E. [4 ]
Marisi, G. [5 ]
Buonfiglioli, F. [3 ]
Ravaioli, M. [3 ]
Mazzella, G. [6 ]
Muratori, P. [7 ,8 ]
Lenzi, M. [7 ,8 ]
Crespi, C. [9 ]
Bolondi, L. [6 ]
Badia, L. [10 ]
Verucchi, G. [3 ]
Vitale, G. [3 ]
Vukotic, R. [3 ]
Brillanti, S. [3 ]
Andreone, P. [3 ]
机构：
[1] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Dept Med Oncol, Meldola, Italy
[2] AUSL Romagna, DPT Internal Med, Faenza Hosp, Forli, Italy
[3] Univ Bologna, Res Ctr Study Hepatitis, Dept Med & Surg Sci DIMEC, Bologna, Italy
[4] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Unit Biostat & Clin Trials, Meldola, Italy
[5] IRST IRCCS, Biosci Lab, Meldola, Italy
[6] Univ Bologna, Dept Med & Surg Sci DIMEC, Bologna, Italy
[7] Policlin St Orsola, Ctr Study & Treatment Autoimmune Dis Liver & Bili, Bologna, Italy
[8] Univ Bologna, Dept Med & Surg Sci DIMEC, Alma Mater Studiorum, Bologna, Italy
[9] St Orsola Marcello Malpighi Hosp, Dept Digest Dis, Bologna, Italy
[10] Univ Bologna, Infect Dis Unit, Dept Med & Surg Sci, Hosp S Orsola Malpighi, Bologna, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2018年 / 50卷 / 01期
关键词：
D O I：
10.1016/j.dld.2018.01.055
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
F-17
引用
收藏
页码：50 / 51
页数：2
相关论文
共 50 条
  • [31] Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy.
    Renzulli, Matteo
    Buonfiglioli, Federica
    Brocchi, Stefano
    Conti, Fabio
    Serio, Ilaria
    Caraceni, Paolo
    Foschi, Francesco G.
    Mazzella, Giuseppe
    Verucchi, Gabriella
    Andreone, Pietro
    Golfieri, Rita
    Brillanti, Stefano
    HEPATOLOGY, 2016, 64 : 223A - 224A
  • [32] Letter: direct-acting agent therapy and HCV-related Child C cirrhosis
    Braillon, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (04) : 476 - 476
  • [33] Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection
    Degasperi, Elisabetta
    D'Ambrosio, Roberta
    Iavarone, Massimo
    Sangiovanni, Angelo
    Aghemo, Alessio
    Soffredini, Roberta
    Borghi, Marta
    Lunghi, Giovanna
    Colombo, Massimo
    Lampertico, Pietro
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (06) : 1183 - +
  • [34] The impact of sarcopenia on the recurrence of hepatocellular carcinoma in HCV-related liver cirrhosis
    Kamachi, Saori
    Ide, Yasushi
    Tsuji, Chika
    Nakashita, Shunya
    Otsuka, Taiga
    Eguchi, Yuichiro
    Ozaki, Iwata
    Miyoshi, Atsushi
    Kitahara, Kenji
    Mizuta, Toshihiko
    HEPATOLOGY, 2013, 58 : 1257A - 1257A
  • [35] Impact of direct-acting antivirals on the recurrence of hepatocellular carcinoma in chronic hepatitis C
    Tagkou, Nikoletta M.
    Goossens, Nicolas
    Negro, Francesco
    HEPATOMA RESEARCH, 2022, 8
  • [36] Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs)
    Cabibbo, G.
    Cacciola, I.
    Cannavo, M. R.
    Madonia, S.
    Calvaruso, V.
    Petta, S.
    Distefano, M.
    Larocca, L.
    Prestileo, T.
    Tine, F.
    Digiacomo, A.
    Bertino, G.
    Giannitrapani, L.
    Benanti, F.
    Davi, A.
    Volpes, R.
    Scalisi, I.
    Iacobello, C.
    Mazzola, G.
    Cartabellotta, F.
    Guarneri, L.
    Portelli, V.
    Averna, A.
    Russello, M.
    Scifo, G.
    Squadrito, G.
    Raimondo, G.
    Craxi, A.
    Di Marco, V.
    Camma, C.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E59 - E59
  • [37] Effect of direct-acting antivirals on hepatocellular carcinoma incidence in hepatitis C virus-related cirrhosis
    Navani, V.
    Chan, P.
    Borchard, J.
    Ladera, A.
    Coppock, J.
    Turner, I.
    Shackel, N.
    Levy, M.
    Davison, S.
    Prakoso, E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 75 - 75
  • [38] OCCURRENCE AND RELAPSE OF HEPATOCELLULAR CARCINOMA IN HEPATITIS C PATIENTS TREATED WITH ALL ORAL DIRECT-ACTING ANTIVIRALS
    Fukuhara, Kyoko
    Yamashina, Shunhei
    Kon, Kazuyoshi
    Uchiyama, Akira
    Fukada, Hiroo
    Shiina, Shuichiro
    Ikejima, Kenichi
    GASTROENTEROLOGY, 2019, 156 (06) : S1202 - S1202
  • [39] Incidence and Risk Factors for Hepatocellular Carcinoma in a Brazilian Cohort of HCV-Related Cirrhotic Patients Treated with Direct-Acting Antiviral Agents
    Cheinquer, Hugo
    De Maman, Italo, Jr.
    De Araujo, Alexandre
    Wolff, Fernando
    Coelho-Borges, Silvia
    Kowacs, Julia
    HEPATOLOGY, 2018, 68 : 391A - 391A
  • [40] Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting Antivirals
    Debes, Jose D.
    van Tilborg, Marjolein
    Groothuismink, Zwier M. A.
    Hansen, Bettina E.
    zur Wiesch, Julian Schulze
    von Felden, Johann
    de Knegt, Robert J.
    Boonstra, Andre
    GASTROENTEROLOGY, 2018, 154 (03) : 515 - +
12345